Maria Gavriatopoulou

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 79

Top Topics

Multiple Myeloma

Systematic Review

Newly Diagnosed

Prognostic Factors

Top Venues

American journal of hematology

Expert review of anticancer therapy

Blood cancer journal

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

This page only lists publications with an associated author ORCID identifier.

Publications

Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology 204 (5) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Ioannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Evangelos Eleutherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Nikolaos Paschalidis, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Evangelos Terpos
Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma. American journal of hematology (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Eirini Katodritou, Dimitra Dalampira, Sosana Delimpasi, Ioannis Ntanasis-Stathopoulos, Fryni Karaolidou, Annita-Ioanna Gkioka, Vasiliki Labropoulou, Emmanouil Spanoudakis, Theodora Triantafyllou, Maria Kotsopoulou, Eyrydiki Michalis, Chrysanthi Vadikolia, Theodosia Papadopoulou, Aggeliki Sevastoudi, Michael Michael, Aikaterini Daiou, Aikaterini Pentidou, Ioannis V Kostopoulos, Vasiliki Palaska, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Evgenia Verrou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group. American journal of hematology (2024)
Despina Fotiou, Foteini Theodorakakou, Sotiria Spiliopoulou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Maria Roussou, Ioannis Ntanasis-Stathopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Thrombotic and bleeding complications in patients with AL amyloidosis. British journal of haematology (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology (2024)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Eirini Katodritou, Evdoxia Hatjiharissi, Panagiotis Malandrakis, Evgenia Verrou, Stavros Golfinopoulos, Magdalini Migkou, Kyriaki Manousou, Sosana Delimpasi, Argiris Symeonidis, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA. American journal of hematology 99 (3) (2024)
Ioannis V Kostopoulos, Despina Fotiou, Maria Gavriatopoulou, Pantelis Rousakis, Ioannis Ntanasis-Stathopoulos, Chrysanthi Panteli, Panagiotis Malandrakis, Magdalini Migkou, Nikolaos Angelis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Foteini Theodorakakou, Maria Krevvata, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Ourania E Tsitsilonis, Efstathios Kastritis
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity. Blood cancer journal 14 (1) (2024)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Giorgos Psarros, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated ocular adverse events and their impact on daily functioning from the part 1 of a phase 1/2 study. American journal of hematology 99 (3) (2024)
Maria Papatsirou, Christos K Kontos, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Christine-Ivy Liacos, Nefeli Mavrianou-Koutsoukou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
ciRS-7 circular RNA overexpression in plasma cells is a promising molecular biomarker of unfavorable prognosis in multiple myeloma. EJHaem 5 (4) (2024)
Despina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, Magdalini Migkou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis Papaiakovou, Evangelos Terpos, Asimina Papanikolaou, Charikleia Gakiopoulou, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with AL amyloidosis in the era of contemporary therapies. European journal of haematology (2023)
Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, Vasiliki Labropoulou, Sosana Delimpasi, Katia Mancuso, Elena Zamagni, Eirini Katodritou, Elena Rivolti, Marie-Christine Kyrtsonis, Maria Roussou, Despina Fotiou, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Evdoxia Hatjiharissi, Nikolaos Kanellias, Magdalini Migkou, Giorgos Cheliotis, Kyriaki Manousou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
Prospective phase 2 trial of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment or on dialysis: The DARE study. American journal of hematology (2023)
Efstathia Liatsou, Diamantis I Tsilimigras, Panagiotis Malandrakis, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos
Current status and novel insights into the role of metastasectomy in the era of immunotherapy. Expert review of anticancer therapy (2022)
Efstathios Kastritis, Magdalini Migkou, Dimitra Dalampira, Maria Gavriatopoulou, Despina Fotiou, Maria Roussou, Nikolaos Kanellias, Ioannis Ntanasis-Stathopoulos, Panagiotis Malandrakis, Foteini Theodorakakou, Aggeliki Sevastoudi, Evangelos Eleutherakis-Papaiakovou, Theodora Triantafyllou, Evangelos Terpos, Eirini Katodritou, Meletios- Athanasios Dimopoulos
Chromosome 1q21 aberrations identify ultra high-risk myeloma with prognostic and clinical implications. American journal of hematology 97 (9) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Efstathia Liatsou, Diamantis I Tsilimigras, Panagiotis Malandrakis, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos
Current status and novel insights into the role of metastasectomy in the era of immunotherapy. Expert review of anticancer therapy 23 (1) (2022)
Efstathia Liatsou, Diamantis I Tsilimigras, Panagiotis Malandrakis, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos
Current status and novel insights into the role of metastasectomy in the era of immunotherapy. Expert review of anticancer therapy 23 (1) (2022)
Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Eleni-Dimitra Papanagnou, Magdalini Migkou, Nikolaos Kanellias, Efstathios Kastritis, Ioannis P Trougakos, Meletios A Dimopoulos
Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy. Blood 139 (9) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology (2022)
Efstathia Liatsou, Diamantis I Tsilimigras, Panagiotis Malandrakis, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos
Current status and novel insights into the role of metastasectomy in the era of immunotherapy. Expert review of anticancer therapy (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 hours post administration in newly diagnosed multiple myeloma patients. American journal of hematology (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Ioannis V Kostopoulos, Ioannis Ntanasis-Stathopoulos, Pantelis Rousakis, Evangelos Eleutherakis-Papaiakovou, Chrysanthi Panteli, Panagiotis Malandrakis, Nikolaos Angelis, Nikolaos Kanellias, Nikolaos Orologas-Stavrou, Aristea-Maria Papanota, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma: Prognostic and More. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Ioannis V Kostopoulos, Antonis Kakalis, Anastasios Birmpilis, Nikolaos Angelis, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos
Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients. American journal of hematology 98 (3) (2022)
Evangelos Terpos, Despina Fotiou, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, Aimilia D Sklirou, Maria Gavriatopoulou, Panagiotis Malandrakis, Vassiliki A Iconomidou, Efstathios Kastritis, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos
SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies. American journal of hematology 97 (10) (2022)
Anastasios Tentolouris, Ioannis Ntanasis-Stathopoulos, Panayotis K Vlachakis, Diamantis I Tsilimigras, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
COVID-19: time to flatten the infodemic curve. Clinical and experimental medicine 21 (2) (2021)
Efstathios Kastritis, Evangelos Terpos, Zoi Evangelakou, Foteini Theodorakakou, Despina Fotiou, Maria S Manola, Despoina D Gianniou, Tina Bagratuni, Nikolaos Kanellias, Magdalini Migkou, Maria Gavriatopoulou, Ioannis P Trougakos, Meletios- Athanasios Dimopoulos
Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy. American journal of hematology (2021)
Maria Gavriatopoulou, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Meletios- Athanasios Dimopoulos
Nonselective proteasome inhibitors in multiple myeloma and future perspectives. Expert opinion on pharmacotherapy (2021)
Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Eleni-Dimitra Papanagnou, Magdalini Migkou, Foteini Theodorakakou, Maria Roussou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Ioannis P Trougakos, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment. Blood cancer journal 11 (8) (2021)
Maria Gavriatopoulou, Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Efstathios Kastritis, Ioannis P Trougakos, Meletios A Dimopoulos
Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study. Blood advances 5 (21) (2021)
Magdalini Migkou, Despina Fotiou, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
Ibrutinib plus rituximab for the treatment of adult patients with Waldenström's macroglobulinemia: a safety evaluation. Expert opinion on drug safety 20 (9) (2021)
Alexandros Briasoulis, Kimon Stamatelopoulos, Ioannis Petropoulos, Raphael Patras, Foteini Theodorakakou, Maria Gavriatopoulou, Argyrios Ntalianis, Meletios-Athanasios Dimopoulos, Efstathios Kastritis
Utilization and tolerance of beta-blockers among patients with AL amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2021)
Sosana Delimpasi, Maria Victoria Mateos, Holger W Auner, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos, Hang Quach, Halyna Pylypenko, Roman Hájek, Xavier Leleu, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P Venner, Reuben Benjamin, Mamta Krishnan Garg, Vadim Doronin, Yair Levy, Phillipe Moreau, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G Kauffman, Paul Gerard Richardson, Sebastian Grosicki
Efficacy and Tolerability of Once-Weekly Selinexor, Bortezomib, and Dexamethasone in Comparison with Standard Twice-Weekly Bortezomib and Dexamethasone in Previously Treated Multiple Myeloma with Renal Impairment: Subgroup Analysis from the BOSTON Study. American journal of hematology (2021)
Evangelos Terpos, Ioannis P Trougakos, Maria Gavriatopoulou, Ioannis Papassotiriou, Aimilia D Sklirou, Ioannis Ntanasis-Stathopoulos, Eleni-Dimitra Papanagnou, Despina Fotiou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose. Blood 137 (26) (2021)
Tina Bagratuni, Athina N Markou, Dimitrios Patseas, Nefeli Mavrianou-Koutsoukou, Foteini D Aktypi, Christine I Liacos, Aimilia D Sklirou, Foteini Theodorakakou, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Ioannis P Trougakos, Evi S Lianidou, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies. Blood advances (2021)
Holger W Auner, Maria Gavriatopoulou, Sosana Delimpasi, Maryana Simonova, Ivan Spicka, Ludek Pour, Meletios- Athanasios Dimopoulos, Iryna Kriachok, Halyna Pylypenko, Xavier Leleu, Vadim Doronin, Ganna Usenko, Roman Hajek, Reuben Benjamin, Tuphan Kanti Dolai, Dinesh Kumar Sinha, Christopher P Venner, Mamta Garg, Don Ambrose Stevens, Hang Quach, Sundar Jagannath, Phillipe Moreau, Moshe Levy, Ashraf Badros, Larry D Anderson, Nizar J Bahlis, Thierry Facon, Maria Victoria Mateos, Michele Cavo, Yi Chai, Melina Arazy, Jatin Shah, Sharon Shacham, Michael G Kauffman, Paul G Richardson, Sebastian Grosicki
Effect of age and frailty on the efficacy and tolerability of once-weekly selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma. American journal of hematology 96 (6) (2021)
Efstathios Kastritis, Pantelis Rousakis, Ioannis V Kostopoulos, Maria Gavriatopoulou, Foteini Theodorakakou, Despina Fotiou, Ioanna Dialoupi, Magdalini Migkou, Maria Roussou, Nikolaos Kanellias, Maria-Irini Tselegkidi, Evangelos Eleutherakis-Papaiakovou, Asimina Papanikolaou, Charikleia Gakiopoulou, Erasmia Psimenou, Marylin Spyropoulou-Vlachou, Anastasia Gatou, Evangelos Terpos, Ourania Tsitsilonis, Meletios- Athanasios Dimopoulos
Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2021)
Efstathios Kastritis, Ageliki Laina, Georgios Georgiopoulos, Maria Gavriatopoulou, Eleni-Dimitra Papanagnou, Evangelos Eleutherakis-Papaiakovou, Despina Fotiou, Nikolaos Kanellias, Ioanna Dialoupi, Nikolaos Makris, Efstathios Manios, Magdalini Migkou, Maria Roussou, Maria Kotsopoulou, Konstantinos Stellos, Evangelos Terpos, Ioannis P Trougakos, Kimon Stamatelopoulos, Meletios A Dimopoulos
Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study. Leukemia 35 (5) (2021)
Eleni Korompoki, Maria Gavriatopoulou, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist. American journal of hematology (2021)
Maria Gavriatopoulou, Evangelos Terpos, Efstathios Kastritis, Alexandros Briasoulis, Sentiljana Gumeni, Ioannis Ntanasis-Stathopoulos, Aimilia D Sklirou, Panagiotis Malandrakis, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Ioannis P Trougakos, Meletios A Dimopoulos
Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine. Clinical and experimental medicine (2021)
Marie José Kersten, Karima Amaador, Monique C Minnema, Josephine M I Vos, Kazem Nasserinejad, Marcel Kap, Efstathios Kastritis, Maria Gavriatopoulou, Willem Kraan, Martine E D Chamuleau, Dries Deeren, Lidwine W Tick, Jeanette K Doorduijn, Fritz Offner, Lara H Böhmer, Roberto D Liu, Steven T Pals, Meletios- Athanasios Dimopoulos
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Ioannis Ntanasis-Stathopoulos, Tina Bagratuni, Maria Gavriatopoulou, Dimitrios Patseas, Christine Liacos, Nikolaos Kanellias, Despina Fotiou, Eleni Tsiligkeridou, Amalia Andreatou, Nefeli Mavrianou-Koutsoukou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Maria Roussou, Evangelos Terpos, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations. American journal of hematology 95 (6) (2020)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Eleni Korompoki, Despina Fotiou, Magdalini Migkou, Ioannis-Georgios Tzanninis, Theodora Psaltopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios A Dimopoulos
Emerging treatment strategies for COVID-19 infection. Clinical and experimental medicine 21 (2) (2020)
Panagiotis Kokotis, Efstathios Manios, Martin Schmelz, Despina Fotiou, Ioanna Dialoupi, Maria Gavriatopoulou, Maria Roussou, Aikaterini Lykka, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Involvement of small nerve fibres and autonomic nervous system in AL amyloidosis: comprehensive characteristics and clinical implications. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 27 (2) (2020)
Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Maria Roussou, Nikolaos Kanellias, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos
Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period. Annals of hematology 99 (6) (2020)
Efstathios Kastritis, Ioannis V Kostopoulos, Foteini Theodorakakou, Despina Fotiou, Maria Gavriatopoulou, Magdalini Migkou, Maria Irini Tselegkidi, Maria Roussou, Alexandra Papathoma, Evangelos Eleutherakis-Papaioakovou, Ioanna Dialoupi, Nikolaos Kanellias, Argyrios Ntalianis, Pantelis Rousakis, Ioannis P Trougakos, Ourania Tsitsilonis, Charikleia Gakiopoulou, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Next generation flow cytometry for MRD detection in patients with AL amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 28 (1) (2020)
Efstathios Kastritis, Foteini Theodorakakou, Maria Roussou, Erasmia Psimenou, Charikleia Gakiopoulou, Smaragdi Marinaki, Anastasia Gatou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Ioanna Dialoupi, Ioannis Ntanasis-Stathopoulos, Ioannis V Kostopoulos, Evangelos Terpos, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance. British journal of haematology 193 (1) (2020)
Maria Gavriatopoulou, Andriani Βoultadaki, Vassilis Koutoulidis, Ioannis Ntanasis-Stathopoulos, Charis Bourgioti, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Lia-Angela Moulopoulos
The Role of Low Dose Whole Body CT in the Detection of Progression of Patients with Smoldering Multiple Myeloma. Blood cancer journal 10 (9) (2020)
Maria Gavriatopoulou, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Meletios- Athanasios Dimopoulos
The current role of BTK inhibitors in the treatment of Waldenstrom's Macroglobulinemia. Expert review of anticancer therapy 20 (8) (2020)
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Evangelos Terpos
Antibody therapies for multiple myeloma. Expert opinion on biological therapy 20 (3) (2020)
Despina Fotiou, Maria Roussou, Charikleia Gakiopoulou, Erasmia Psimenou, Maria Gavriatopoulou, Magdalini Migkou, Nikolaos Kanellias, Ioanna Dialoupi, Evangelos Eleutherakis-Papaiakovou, Stavroula Giannouli, Christina Delavinia, Kostantinos Efstathiou, Sofoklis Kontogiannis, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Efstathios Kastritis
Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients. Blood cancer journal 10 (11) (2020)
Maria Gavriatopoulou, Eleni Korompoki, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Theodora Psaltopoulou, Efstathios Kastritis, Evangelos Terpos, Meletios A Dimopoulos
Organ-specific manifestations of COVID-19 infection. Clinical and experimental medicine 20 (4) (2020)
Ioannis Ntanasis-Stathopoulos, Diamantis I Tsilimigras, Maria Gavriatopoulou, Dimitrios Schizas, Timothy M Pawlik
Cholangiocarcinoma: investigations into pathway-targeted therapies. Expert review of anticancer therapy 20 (9) (2020)
Efstathios Kastritis, Nikolaos Kanellias, Foteini Theodorakakou, Erasmia Psimenou, Charikleia Gakiopoulou, Smaragdi Marinaki, Maria Roussou, Maria Gavriatopoulou, Magdalini Migkou, Despina Fotiou, Evangelos Eleutherakis-Papaiakovou, Panagiotis Malandrakis, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause. Leukemia & lymphoma 61 (13) (2020)
Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiří Minařík, Ioannis Ntanasis-Stathopoulos, Eirini Katodritou, Matthew W Jenner, Hana Plonkova, Maria Gavriatopoulou, Grant D Vallance, Tomas Pika, Maria Kotsopoulou, Jaimal Kothari, Tomas Jelinek, Efstathios Kastritis, Robin Aitchison, Meletios- Athanasios Dimopoulos, Athanasios Zomas, Roman Hájek
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma. Annals of hematology 99 (5) (2020)
Efstathios Kastritis, Despina Fotiou, Foteini Theodorakakou, Ioanna Dialoupi, Magdalini Migkou, Maria Roussou, Eleni A Karatrasoglou, Maria Irini Tselegkidi, Argyrios Ntalianis, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Ioannis Ntanasis-Stathopoulos, Charikleia Gakiopoulou, Asimina Papanikolaou, Alexandra Papathoma, Marylin Spyropoulou-Vlachou, Erasmia Psimenou, Kimon Stamatelopoulos, Maria Gavriatopoulou, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 28 (1) (2020)
Eirini Katodritou, Efstathios Kastritis, Moshe E E Gatt, Yael C Cohen, Irit Avivi, Anastasia Pouli, Chrysavgi Lalayianni, Noa Lavi, Sosana Delimpasis, Marie-Christine Kyrtsonis, Michalis Michael, Celia Suriu, Zektser Miri, Katrin Tzafarti, Chrysanthi Vadikoliou, Dimitris Maltezas, Panagiotis Zikos, Chezi Ganzel, Yuliana Vaxman, Ariel Aviv, Anna Christoforidou, Maria Gavriatopoulou, Adir Shaulov, Evgenia Verrou, Aristea-Maria Papanota, Gabriel Fakinos, Annita-Ioanna Gkioka, Vasiliki Palaska, Theodora Triantafyllou, Pavlina Konstantinidou, Achilles Anagnostopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group. American journal of hematology 95 (5) (2020)
Aristea-Maria Papanota, Ioannis Ntanasis-Stathopoulos, Aliki Liakea, Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos, Maria Gavriatopoulou
Primary plasma cell leukemia presenting as secondary pulmonary alveolar proteinosis. Leukemia & lymphoma 61 (9) (2020)
Evangelos Terpos, Efstathios Kastritis, Ioannis Ntanasis-Stathopoulos, Dimitrios Christoulas, Athanasios Papatheodorou, Evangelos Eleutherakis-Papaiakovou, Nikolaos Kanellias, Despina Fotiou, Dimitrios C Ziogas, Magdalini Migkou, Maria Roussou, Ioannis P Trougakos, Maria Gavriatopoulou, Meletios- Athanasios Dimopoulos
Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates. American journal of hematology 94 (4) (2019)
Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Meletios Athanasios Dimopoulos, Evangelos Terpos
Anti-BCMA antibodies in the future management of multiple myeloma. Expert review of anticancer therapy 19 (4) (2019)
Despina Fotiou, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Magdalini Migkou, Meletios A Dimopoulos, Evangelos Terpos
Updates on thrombotic events associated with multiple myeloma. Expert review of hematology 12 (5) (2019)
Theodoros N Sergentanis, Ioannis Ntanasis-Stathopoulos, Ioannis-Georgios Tzanninis, Maria Gavriatopoulou, Ioannis N Sergentanis, Meletios- Athanasios Dimopoulos, Theodora Psaltopoulou
Meat, fish, dairy products and risk of hematological malignancies in adults - a systematic review and meta-analysis of prospective studies. Leukemia & lymphoma 60 (8) (2019)
Evangelos Eleutherakis-Papaiakovou, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Elotuzumab in combination with pomalidomide and dexamethasone for the treatment of multiple myeloma. Expert review of anticancer therapy 19 (11) (2019)
Mark Bustoros, Efstathios Kastritis, Romanos Sklavenitis-Pistofidis, Chia-Jen Liu, Kalvis Hornburg, Nikolaos Kanellias, Geon Kim, David Liu, Maria Gavriatopoulou, Catherine R Marinac, Maria Roussou, Magdalini Migkou, Kimberly Noonan, Kaitlen Reyes, Bradley Rivotto, Carl Jannes Neuse, Dimitrios C Ziogas, Jacob Laubach, Evangelos Terpos, Kenneth C Anderson, Paul G Richardson, Irene M Ghobrial, Meletios- Athanasios Dimopoulos
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group. American journal of hematology 94 (5) (2019)
Efstathios Kastritis, Maria Gavriatopoulou, Maria Roussou, Tina Bagratuni, Magdalini Migkou, Despina Fotiou, Dimitrios C Ziogas, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Ioanna Dialoupi, Ioannis Ntanasis-Stathopoulos, Mairylin Spyropoulou-Vlachou, Erasmia Psimenou, Harikleia Gakiopoulou, Smaragdi Marinaki, Elektra Papadopoulou, Argyrios Ntalianis, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (4) (2019)
Maria Gavriatopoulou, Despina Fotiou, Ursula Koloventzou, Maria Roussou, Magdalini Migkou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Dimitrios C Ziogas, Ioannis Panagiotidis, Dimitra Gika, Evangelos Eleutherakis-Papaiakovou, Evangelos Terpos, Efstathios Kastritis, Meletios Athanasios Dimopoulos
Vulnerability variables among octogenerian myeloma patients: a single-center analysis of 110 patients. Leukemia & lymphoma 60 (3) (2019)
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou, Nikolaos Kanellias, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Evangelos Terpos
Screening for Gaucher disease among patients with plasma cell dyscrasias. Leukemia & lymphoma 62 (3) (2019)
Nikolaos Kanellias, Maria Gavriatopoulou, Evangelos Terpos, Meletios Athanasios Dimopoulos
Management of multiple myeloma bone disease: impact of treatment on renal function. Expert review of hematology 11 (11) (2018)
Theodora Psaltopoulou, Ioannis Ntanasis-Stathopoulos, Diamantis I Tsilimigras, Ioannis-Georgios Tzanninis, Maria Gavriatopoulou, Theodoros N Sergentanis
Micronutrient Intake and Risk of Hematological Malignancies in Adults: A Systematic Review and Meta-analysis of Cohort Studies. Nutrition and cancer 70 (6) (2018)
Magdalini Migkou, Maria Gavriatopoulou, Evangelos Terpos, Meletios Athanasios Dimopoulos
Optimizing therapy in bortezomib-exposed patients with multiple myeloma. Expert review of hematology 11 (6) (2018)